Optomed's Board of Directors Resolves New Stock Option Plan

Optomed Plc's Board of Directors has resolved to establish a new stock option plan, based on an authorization granted by the General Meeting on May 8, 2026.

The new Option Plan 2026A comprises a total of 613,130 options, with each option entitling the holder to one company share. The plan is directed towards the company's CEO and certain key employees.

The purpose of the plan is to retain and incentivize the CEO and other key employees. This is a common practice for publicly listed companies to ensure staff retention and motivation.

Optomed specializes in diagnostic solutions for eye diseases, utilizing augmented reality technology. The company's innovations facilitate early detection and monitoring of various ocular conditions.